The aim is to identify biomarkers that differentiate cerebral malaria from other coma causes in children.
Identification of angiopoietin-like 4 and inhibin-βE as potential biomarkers.
Evaluation of their effectiveness in diagnosing cerebral malaria.
Angiopoietin-like 4 and inhibin-βE show promise as diagnostic tools.
These biomarkers could improve accuracy in differentiating cerebral malaria.
Abstract
Angiopoietin-like 4 and Inhibin-βE could be developed as a diagnostic tool for the differentiation of comatose patients with CM from other causes of coma.